A neutron irradiation cavity for in vivo activation analysis has been characterized to estimate its dosimetric specifications. The cavity is defined to confine irradiation to the hand and modifies the neutron spectrum produced by a low energy accelerator neutron source to optimize activation per dose. Neutron and gamma-ray dose rates were measured with the microdosimetric technique using a tissue-equivalent proportional counter at the hand irradiation site and inside the hand access hole. For the outside of the cavity, a spherical neutron dose equivalent meter and a Farmer dosemeter were employed instead due to the low intensity of the radiation field. The maximum dose equivalent rate at the outside of the cavity was 2.94 microSv/100 microA min, which is lower by a factor of 1/2260 than the dose rate at the hand irradiation position. The local dose contributions from a hand, an arm and the rest of a body to the effective dose rate were estimated to be 1.73, 0.782 and 2.94 microSv/100 microA min, respectively. For the standard irradiation protocol of the in vivo hand activation, 300 microA min, an effective dose of 16.3 microSv would be delivered.
Large-field photon radiotherapy is current standard in the treatment of cervical cancer patients. However, with the increasing availability of Pencil Beam Scanning Proton Therapy (PBS-PT) and robust treatment planning techniques, protons may have significant advantages for cervical cancer patients in the reduction of toxicity. In this study, PBS-PT and photon Volumetric Modulated Arc Therapy (VMAT) were compared, examining target coverage and organ at risk (OAR) dose, taking inter- and intra-fraction motion into account. Twelve cervical cancer patients were included in this in-silico planning study. In all cases, a planning CT scan, five weekly repeat CT scans (reCTs) and an additional reCT 10 min after the first reCT were available. Two-arc VMAT and robustly optimised two- and four-field (2F and 4F) PBS-PT plans were robustly evaluated on planCTs and reCTs using set-up and range uncertainty. Nominal OAR doses and voxel-wise minimum target coverage robustness were compared. Average voxel-wise minimum accumulated doses for pelvic target structures over all patients were adequate for both photon and proton treatment techniques (D98 > 95%, [91.7-99.3%]). Average accumulated dose of the para-aortic region was lower than the required 95%, D98 > 94.4% [91.1-98.2%]. With PBS-PT 4F, dose to all OARs was significantly lower than with VMAT. Major differences were observed for mean bowel bag V15Gy: 60% [39-70%] for VMAT vs 30% [10-52%] and 32% [9-54%] for PBS-PT 2F and 4F and for mean bone marrow V10Gy: 88% [82-97%] for VMAT vs 66% [60-73%] and 67% [60-75%] for PBS-PT 2F and 4F. Robustly optimised PBS-PT for cervical cancer patients shows equivalent target robustness against inter- and intra-fraction variability compared to VMAT, and offers significantly better OAR sparing.
1 July 2011 in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
Neutron spectrometry and subsequent dosimetry measurements were undertaken at the McMaster Nuclear Reactor (MNR) and AECL Chalk River National Research Universal (NRU) Reactor. The instruments used were a Bonner sphere spectrometer (BSS), a cylindrical nested neutron spectrometer (NNS) and a commercially available rotational proton recoil spectrometer. The purposes of these measurements were to: (1) compare the results obtained by three different neutron measuring instruments and (2) quantify neutron fields of interest. The results showed vastly different neutron spectral shapes for the two different reactors. This is not surprising, considering the type of the reactors and the locations where the measurements were performed. MNR is a heavily shielded light water moderated reactor, while NRU is a heavy water moderated reactor. The measurements at MNR were taken at the base of the reactor pool, where a large amount of water and concrete shielding is present, while measurements at NRU were taken at the top of the reactor (TOR) plate, where there is only heavy water and steel between the reactor core and the measuring instrument. As a result, a large component of the thermal neutron fluence was measured at MNR, while a negligible amount of thermal neutrons was measured at NRU. The neutron ambient dose rates at NRU TOR were measured to be between 0.03 and 0.06 mSv h−1, while at MNR, these values were between 0.07 and 2.8 mSv h−1 inside the beam port and <0.2 mSv h−1 between two operating beam ports. The conservative uncertainty of these values is 15 %. The conservative uncertainty of the measured integral neutron fluence is 5 %. It was also found that BSS over-responded slightly due to a non-calibrated response matrix.
1 February 2015 in Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment